文献速递主动脉疾病

腹主动脉瘤治疗并发症与死亡报告质量:系统综述

Reporting of Complications and Mortality in Relation to Risk Communication in Patients with an Abdominal Aortic Aneurysm: A Systematic Review.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-05-23

本文系统综述2010年以来比较或登记无症状腹主动脉瘤初次治疗研究的并发症与死亡报告质量,按SVS报告标准与CONSORT声明评分。共纳入47篇,19%未定义并发症,30%无法判断为事件数还是患者数,比较两种治疗时仅3.1%给出绝对风险差。

要点

  • 腹主动脉瘤治疗风险报告质量差异大,并发症定义与计数单位常不明确。
  • 比较两种治疗时,极少报告绝对风险差,不利于循证风险沟通。
  • 建议遵循SVS报告标准与CONSORT声明,并明确给出绝对风险差。

核心结论

  • 腹主动脉瘤初次治疗并发症与死亡报告质量差异较大,遵循SVS报告标准与CONSORT声明并给出绝对风险差可改善报告质量、促进循证风险沟通。

研究设计与样本

  • 系统综述,纳入2010年以来的随机临床试验、比较性观察研究与登记研究,限报告无症状腹主动脉瘤初次治疗患者并发症和/或死亡者,共纳入47篇出版物。
  • 由两名作者独立进行筛选、质量评价与数据提取,按SVS报告标准与CONSORT声明中与风险沟通相关的条目评分。

主要发现

  • 47篇出版物中9篇(19%)未提供并发症定义。
  • 47篇中14篇(30%)无法判断呈现的是不良事件数还是发生不良事件的患者数。
  • 在比较两种治疗并发症的32篇中,仅1篇(3.1%)提供绝对风险差。

关键数值与推荐

  • 并发症定义缺失:9/47(19%)。
  • 事件计数单位不明:14/47(30%)。
  • 并发症比较中报告绝对风险差:1/32(3.1%)。
  • 死亡比较中报告绝对风险差:2/31(6.5%)。

临床怎么用

  • 阅读腹主动脉瘤治疗文献时应核查并发症定义与计数单位,避免误读风险。
  • 向患者沟通治疗风险时优先采用绝对风险差,而非仅相对风险。
  • 开展或报告腹主动脉瘤研究时遵循SVS报告标准与CONSORT声明。

局限性

  • 仅纳入2010年以来符合条件的随机临床试验、比较性观察研究与登记研究。
  • 质量评价限于SVS报告标准与CONSORT声明中与风险沟通相关的条目。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: High-quality reporting of surgical risks is necessary for evidence-based risk communication in clinical practice. Risk communication is defined as the process of discussing benefits and harms of treatment options with patients. This review addressed the current quality of reporting of complications and mortality in publications on abdominal aortic aneurysm treatment, with a focus on items relevant to risk communication. DESIGN: A systematic review. MATERIALS: Randomised clinical trials, comparative observational studies and registries from 2010 onwards were eligible if they reported complications and/or mortality in patients with an asymptomatic abdominal aortic aneurysms who received primary treatment. METHODS: Quality of reporting was assessed by scoring items relevant to risk communication from the reporting standards of the Society for Vascular Surgery (SVS) and the Consolidated Standards of Reporting Trials (CONSORT) statement. Screening, quality assessment and data extraction were independently undertaken by two authors. RESULTS: Forty-seven publications were included. Nine of 47 publications (19%) provided no definition of complications. In 14 of 47 publications (30%), it was unclear whether the number of adverse events or the number of patients with adverse events were presented. Absolute risk differences were provided in 1 of 32 publications (3.1%) that compared complications between two treatment options. Forty-six of 47 publications reported mortality, of which 42 reported overall mortality rates (91%). Absolute risk differences were given in 2 of the 31 publications (6.5%) that compared mortality between two treatment options. CONCLUSIONS: The quality of reporting of complications and mortality following primary abdominal aortic aneurysm treatment varied considerably. Better adherence to the SVS reporting standards and the CONSORT statement, as well as stating absolute risk differences may improve the quality of reporting and facilitate evidence-based risk communication.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. de Mik SML, Indrakusuma R, Legemate DA, et al. Reporting of Complications and Mortality in Relation to Risk Communication in Patients with an Abdominal Aortic Aneurysm: A Systematic Review. Eur J Vasc Endovasc Surg. 2019. PMID: 31128986. doi:10.1016/j.ejvs.2019.01.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。